Blenrep News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Blenrep. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Blenrep Today - Breaking & Trending Today

Blenrep Combo for Relapsed, Refractory Myeloma Improves Outcomes

Patients with relapsed or refractory multiple myeloma had lower progressive disease outcomes when receiving Blenrep with Velcade and dexamethasone, research found. ....

Castillay Leóp , Hesham Abdullah , University Of Salamanca , National Cancer Institute , National Cancer , Victoria Mateos , Multiple Myeloma ,

GSK Drug Pulled From Market Beats J&J Multiple Myeloma Med in Phase 3 Test

GSK took Blenrep off the market last year after the multiple myeloma drug failed its confirmatory study. But GSK now says it has interim data showing Blenrep beat a blockbuster Johnson & Johnson drug in a head-to-head Phase 3 study testing it as an earlier line of therapy. ....

Hesham Abdullah , Bristol Myers Squibb , Weight Loss , Medical Devices , Healthcare Innovation , Medcity News , Medcity News , San Francisco , Life Sciences , Rock Health , Startup Advice , Startup Funding , Patient Monitoring System , Otion Sensors , Healthcare It , Foodborne Pathogens , Iagnostics Company , Iagnostic Platforms , Minimally Invasive Surgery , Aser Surgery , Ealth And Wellness , Mployee Wellness Programs , Hanghai Innovation Center , R D , Twin Cities , Ulcerative Colitis ,

GSK will focus more on HIV and infectious disease treatment, and less on cancer

In a major departure from his predecessor, head of research Tony Wood says he is de-emphasising R&D in oncology ....

United States , United Kingdom , Emma Walmsley , Michael Leuchten , Hal Barron , Eli Lilly , Tony Wood , University Of California , Credit Suisse , Drug Administration , Novo Nordisk , Altos Labs , 160323 Intbus Gsk , Us Food And Drug Administration , Pd 1 , Usiness Live ,

GSK halts US sales of its blood cancer drug Blenrep

British pharmaceutical firm GSK announced that it will stop selling its blood cancer drug Blenrep in the United States. The company announced on Nov. 22 that it has begun the process to withdraw [.] ....

United States , United Kingdom , Sabine Luik , Health Ranger , Health Ranger Mike Adams , European Union , Drug Administration , Natural News , Driving Excellence , Multiple Myeloma , Medical Officer , Massachusetts Based Tesaro , Health Ranger Report , Big Pharma , Cancer Industry , Harmful Medicine , Antibody Drug Conjugates , Blood Cancer , Dangerous Medicine , Market Authorization , Ovarian Cancer , Parp Inhibitors , Pharmaceutical Fraud , Poly Adp Ribose Polymerase ,

GSK to stop selling blood cancer drug Blenrep in United States

GSK will stop selling its blood cancer drug Blenrep in the United States, it said on Tuesday, representing the latest in a series of setbacks for the Briti.. ....

United States , United Kingdom , Sabine Luik , European Union , Drug Administration , Medical Officer Sabine Luik , United States ,